Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
153
6 regions40 stories15 countries
Top story
Health insurance cannabis sales in Germany hit record €15m in March 2020
DEMedicallink no longer available
- 01
March 2020 German cannabis sales surge may reflect COVID-19 prescription redemptions
DEMedicallink no longer available
- 02
Prohibition Partners releases full analysis of German cannabis market data
Events & Industrylink no longer available
- 03
Prohibition Partners market analysis available
Events & Industrylink no longer available
Europe
7 stories- German cannabinoids sales climb to reach US$16.8 million in March
DEHemp & CBDlink no longer available
- Is the CBD bubble about to burst?
Hemp & CBDlink no longer available
- Leading professor says UK medicinal cannabis has reached an impasse on clinical trials
GBMedicallink no longer available
- Swiss lawmakers to consider expanding medical cannabis access
CHMedicallink no longer available
- British cannabis campaigners call on government to improve patient access
GBMedicallink no longer available
- Czech extraction facility receives approval to export full-spectrum hemp extract to Spain
- CBDepot group announces new EU GMP compliant manufacturing site for CBD APIs
EUHemp & CBDlink no longer available
United States
7 stories- Canopy Growth reaches agreement to amend its deal to purchase Acreage Holdings
USCABusiness & Investmentlink no longer available
- Veterans health commission recommends furthering cannabis and psychedelics research
USHealth & Sciencelink no longer available
- Oklahoma Supreme Court clears cannabis legalisation measure for signature gathering
USRegulationlink no longer available
- LA city council gives initial approval to cannabis social equity programme overhaul
USAdult-uselink no longer available
- Massachusetts posts lukewarm recreational cannabis sales for first week of reopening
USAdult-uselink no longer available
- New Jersey to phase out medical cannabis sales taxes by July 2022
USRegulationlink no longer available
- MedMen loses provisional medical cannabis business licence in Virginia
USRegulationlink no longer available
Canada
6 stories- Ontario cannabis market surpasses 100 cannabis retail store authorisations
CAAdult-uselink no longer available
- Cannabis retail sales fall slightly 0.6% in April after stockpiling in March
CAAdult-uselink no longer available
- Retailers in British Columbia seek approval for cannabis delivery
CAAdult-uselink no longer available
- Aurora Cannabis to close five facilities and lay off 700 workers during restructuring
CABusiness & Investmentlink no longer available
- Canopy Growth to target cannabis-infused vapes and drinks in bounce back effort
CABusiness & Investmentlink no longer available
- Regulators issue cease trade order for Sunniva pending overdue financial statements
CABusiness & Investmentlink no longer available
LATAM & Caribbean
2 stories- British Virgin Islands projected to make annual US$30 million future cannabis exports
VGBusiness & Investmentlink no longer available
- Colombia's justice minister says cannabis is a financial opportunity post-coronavirus
COBusiness & Investmentlink no longer available
Africa & Middle East
3 stories- Israel's Knesset plenum votes to advance two cannabis legalisation bills
ILRegulationlink no longer available
- South Africa cements new down-scheduled status of CBD and cannabis
ZARegulationlink no longer available
- Israel's Univo imports cannabis from Lesotho and gains approval for Canadian imports
ILLSCABusiness & Investmentlink no longer available
Oceania
3 stories- Medical cannabis approvals show triple-digit annual growth in Australia
AUMedicallink no longer available
- Australian TGA to review complaints of alleged non-compliant cannabis advertising
AURegulationlink no longer available
- New Zealand's Kāriki Pharma signs agreement paving way for exports to Germany
NZDEBusiness & Investmentlink no longer available
Health & Science
- Epilepsy patients overwhelmingly prefer plant-derived CBD over synthetic equivalent
Medicallink no longer available
- CBD reduces behavioural problems in children with intellectual disabilities, study finds
Health & Sciencelink no longer available
- Women found to experience same cannabis effects at lower THC dosage than men
Health & Sciencelink no longer available
Psychedelics
- US military invests US$27 million in developing psychedelics-inspired drugs
USPsychedelicslink no longer available
- Poll shows 59% of Canadians support legalising psilocybin use for terminally ill
CAPsychedelicslink no longer available
- Iowa rejects psilocybin decriminalisation amendment in floor vote
USPsychedelicslink no longer available
- Former Canadian health minister joins Red Light Holland advisory board
CABusiness & Investmentlink no longer available
- MindMed files patent applications for MDMA and LSD dosing screening
CAPsychedelicslink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report